PODDInsulet Corporation
Is it safe?
Strong, no red flags: a safe balance sheet and insiders buying.
Financially healthy, low distress risk Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.
Mixed fundamental signals Piotroski F-score, nine pass/fail tests of year-over-year financial health across profitability, balance sheet and efficiency. 7 to 9 is strong, 0 to 3 weak.
Insiders were net buyers (+$162K, 90 days to Oct 8, 2026). SEC Form 4 filings: officers and directors must report their own trades within two business days.
Investment-grade balance sheet. A rule of thumb on leverage, not a credit rating.
Moderate price swings, typical volatility. Worst drawdown -63% · now 61% below its 52-week high.
Unless marked, from SEC EDGAR, as of Dec 31, 2025.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can PODD take a bad year?
Insulet Corporation carries $414M of net debt at 0.69× EBITDA: a load its earnings can carry.
Net debt · as at Q2 2026 · under two and a half years of EBITDA, comfortable
- Net debt / EBITDA
- 0.69×
Net debt / EBITDA · 0.61× a year ago · the load is going up
- Altman Z-score
- 5.66
Altman Z-score · safe zone, above 3
- Interest cover
- 8.79×
Interest cover · operating profit covers the interest bill several times over
Details›
- Total debtQ2 2026
- $948M
- Cash and short-term investments
- $535M
- Net debt
- $414M
- EBITDA, trailing twelve months
- $596M
- Operating profit, trailing twelve months
- $516M
- Debt / equity
- 0.67×
- Total debt / EBITDA
- 1.59×
- Annualised volatilitytwo years of daily moves
- 41%
- Worst drawdown on file
- −63%
- Below its 52-week high
- 61%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Medical Devices
The closest names by size in the same industry